BSE Live
Jul 31, 16:01Prev. Close
5.10
Open Price
5.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jul 31, 15:40Prev. Close
4.95
Open Price
5.25
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Vivimed Labs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 103.60 | 136.80 | 176.83 | 217.65 | 208.62 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 103.60 | 136.80 | 176.83 | 217.65 | 208.62 | |
| Total Operating Revenues | 103.60 | 136.80 | 176.83 | 218.37 | 210.05 | |
| Other Income | 4.19 | 9.57 | 0.24 | 1.26 | 6.08 | |
| Total Revenue | 107.79 | 146.37 | 177.06 | 219.63 | 216.12 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 60.12 | 85.39 | 184.21 | 142.92 | 92.76 | |
| Purchase Of Stock-In Trade | 1.66 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 11.87 | 25.43 | 28.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.44 | -18.07 | 84.42 | 0.49 | 4.31 | |
| Employee Benefit Expenses | 23.04 | 29.45 | 28.70 | 31.68 | 26.45 | |
| Finance Costs | 2.53 | 1.90 | 35.28 | 39.53 | 41.49 | |
| Depreciation And Amortisation Expenses | 18.63 | 18.41 | 106.91 | 17.45 | 15.80 | |
| Other Expenses | 36.74 | 67.84 | 55.80 | 27.07 | 30.83 | |
| Total Expenses | 139.29 | 184.92 | 507.19 | 284.56 | 239.63 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -31.50 | -38.55 | -330.13 | -64.94 | -23.51 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -31.50 | -38.55 | -330.13 | -64.94 | -23.51 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.00 | -2.12 | 2.82 | -0.23 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.00 | 0.00 | -2.12 | 2.82 | -0.23 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -31.50 | -38.55 | -328.01 | -67.75 | -23.28 | |
| Profit/Loss From Continuing Operations | -31.50 | -44.38 | -328.01 | -67.75 | -23.28 | |
| Profit/Loss For The Period | -31.50 | -44.38 | -328.01 | -67.75 | -23.28 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -3.80 | -5.35 | -39.56 | -8.17 | -3.52 | |
| Diluted EPS (Rs.) | -3.69 | -5.20 | -38.40 | -7.93 | -3.42 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
24.06.2025
Vivimed Labs Standalone March 2025 Net Sales at Rs 22.58 crore, down 37.95% Y-o-Y
03.06.2025
Vivimed Labs Consolidated March 2025 Net Sales at Rs 25.61 crore, down 33.67% Y-o-Y
04.03.2025
Vivimed Labs Consolidated December 2024 Net Sales at Rs 36.51 crore, down 11.94% Y-o-Y
16.02.2024
Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y